Literature DB >> 10103173

Aminoglycosides: activity and resistance.

M P Mingeot-Leclercq1, Y Glupczynski, P M Tulkens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103173      PMCID: PMC89199     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  101 in total

1.  Mechanism of aminoglycoside 3'-phosphotransferase type IIIa: His188 is not a phosphate-accepting residue.

Authors:  P R Thompson; D W Hughes; G D Wright
Journal:  Chem Biol       Date:  1996-09

2.  A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties.

Authors:  R Okachi; I Kawamoto; S Takasawa; M Yamamoto; S Sato
Journal:  J Antibiot (Tokyo)       Date:  1974-10       Impact factor: 2.649

3.  Biologically important conformations of aminoglycoside antibiotics bound to an aminoglycoside 3'-phosphotransferase as determined by transferred nuclear Overhauser effect spectroscopy.

Authors:  J R Cox; E H Serpersu
Journal:  Biochemistry       Date:  1997-03-04       Impact factor: 3.162

4.  Antibiotic G418, a new micrommomospora-produced aminglycoside with activity apainst protozoa and helminths: antiparasitic activity.

Authors:  D Loebenberg; M Counels; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

5.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

Authors:  G H Miller; F J Sabatelli; R S Hare; Y Glupczynski; P Mackey; D Shlaes; K Shimizu; K J Shaw
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

6.  Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.

Authors:  Y Wang; K Hamasaki; R R Rando
Journal:  Biochemistry       Date:  1997-01-28       Impact factor: 3.162

7.  Synthesis of dibekacin analogs containing 3-oxa- and 3-aza-2,3,4-trideoxy-D-glycero-hexopyranose.

Authors:  R Kuwahara; T Tsuchiya
Journal:  Carbohydr Res       Date:  1996-10-23       Impact factor: 2.104

8.  Recognition of aminoglycoside antibiotics by enterococcal-staphylococcal aminoglycoside 3'-phosphotransferase type IIIa: role of substrate amino groups.

Authors:  G A McKay; J Roestamadji; S Mobashery; G D Wright
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

9.  MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition.

Authors:  R Edgar; E Bibi
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

10.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

View more
  178 in total

Review 1.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Novel 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ic, from a Pseudomonas aeruginosa integron.

Authors:  Maria Letizia Riccio; Jean-Denis Docquier; Emanuela Dell'Amico; Francesco Luzzaro; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli.

Authors:  Roopal Mehta; W Scott Champney
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes.

Authors:  Ido M Herzog; Keith D Green; Yifat Berkov-Zrihen; Mark Feldman; Roee R Vidavski; Anat Eldar-Boock; Ronit Satchi-Fainaro; Avigdor Eldar; Sylvie Garneau-Tsodikova; Micha Fridman
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-12       Impact factor: 15.336

6.  Coagulase-negative staphylococcal skin carriage among neonatal intensive care unit personnel: from population to infection.

Authors:  Vishal Hira; Marcel Sluijter; Wil H F Goessens; Alewijn Ott; Ronald de Groot; Peter W M Hermans; René F Kornelisse
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

Review 7.  Small-Molecule Acetylation by GCN5-Related N-Acetyltransferases in Bacteria.

Authors:  Rachel M Burckhardt; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-15       Impact factor: 11.056

Review 8.  Lag Phase Is a Dynamic, Organized, Adaptive, and Evolvable Period That Prepares Bacteria for Cell Division.

Authors:  Robert L Bertrand
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

9.  Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.

Authors:  Jie Li; Fang-I Chiang; Hsiao-Nung Chen; Cheng-Wei Tom Chang
Journal:  Bioorg Med Chem       Date:  2007-09-01       Impact factor: 3.641

10.  Plasmid-mediated 16S rRNA methylases in aminoglycoside-resistant Enterobacteriaceae isolates in Shanghai, China.

Authors:  Qiong Wu; Yibo Zhang; Lizhong Han; Jingyong Sun; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.